Fig. 3From: Comparison of the regressive effects of aflibercept and brolucizumab on pigment epithelial detachmentChanges in the horizontal maximum diameter (H-MD) of pigment epithelial detachment in the intravitreal aflibercept (IVA) and intravitreal brolucizumab (IVBr) groups before and at 1, 2, and 3 months after the first treatment. *; P < 0.05Back to article page